Valero Energy Corp (VLO) 63.62 $VLO Valero Energy: Still

New Post Public Reply Private Reply Replies (0) Message Board
Stock_Tracker
Valero Energy Corp (VLO) 63.62 $VLO

Valero Energy: Still Not Stopped By Cheap Oil
DAG Investments - at Seeking Alpha - Tue Mar 31, 1:46AM CDT

VLO: 63.62 (-0.14)

Here's How A Proxy War In Yemen Could Impact North American Refiners
Tristan R. Brown - at Seeking Alpha - Sun Mar 29, 2:46PM CDT

PSX: 78.60 (-0.96), REX: 60.81 (+0.81), XOM: 85.00 (-0.63), WNR: 49.39 (-0.36), HFC: 40.27 (-0.50), SU: 29.25 (+0.05), VLO: 63.62 (-0.14), REGI: 9.22 (-0.34), ADM: 47.40 (-0.02), TSO: 91.29 (+0.14), MPC: 102.39 (-0.51), GPRE: 28.55 (+0.89), BP: 39.11 (-0.73), NTI: 25.34 (+0.12), PEIX: 10.79 (+0.14), CVX: 104.98 (-1.92), ALJ: 16.57 (+0.59), FF: 10.27 (-0.07), CLMT: 24.05 (-0.79), DK: 39.75 (-0.16)

Valero Energy Falls 2.38% on Heavy Volume: Watch For Potential Rebound
Comtex SmarTrend(R) - Fri Mar 27, 3:49PM CDT
Valero Energy (NYSE:VLO) traded in a range yesterday that spanned from a low of $61.40 to a high of $64.40. Yesterday, the shares fell 2.4%, which took the trading range below the 3-day low of $61.89 on volume of 7.6 million shares. Often times after large one-day declines, short-term traders may play for some degree of mean reversion.
VLO: 63.62 (-0.14)

Valero Energy (VLO) Stock Is Down Today as Oil Prices Fall
at The Street - Fri Mar 27, 2:21PM CDT
Valero Energy (VLO) is falling Friday as oil prices decline after five days of gains.
VLO: 63.62 (-0.14)

General Electric's Unit Acquires Langhope Rig Wind Farm - Analyst Blog
Zacks Equity Research - Zacks Investment Research - Fri Mar 27, 9:40AM CDT
GE Energy Financial Services, a unit of General Electric (GE), expanded its international wind portfolio with the acquisition of 16-megawatt Langhope Rig wind farm from SSE plc.
VLO: 63.62 (-0.14), CODI: 17.10 (-0.05), GE: 24.81 (-0.31), C: 51.52 (-0.12)

The Zacks Analyst Blog Highlights: Methode Electronics, Newmont Mining, Valero Energy and Quest Diagnostics - Press Releases
Zacks Equity Research - Zacks Investment Research - Fri Mar 27, 8:30AM CDT
The Zacks Analyst Blog Highlights: Methode Electronics, Newmont Mining, Valero Energy and Quest Diagnostics
VLO: 63.62 (-0.14), DGX: 76.85 (-0.84), NEM: 21.71 (-0.31), MEI: 47.04 (+0.09)

Can Valero Energy (VLO) Keep the Earnings Streak Alive This Quarter? - Tale of the Tape
Zacks Equity Research - Zacks Investment Research - Fri Mar 27, 7:56AM CDT
Valero Energy Corporation (VLO) has seen a nice streak of beating earnings estimates, especially when looking at the previous two reports
VLO: 63.62 (-0.14)

“Imported Oil is Not Your Enemy. It Is Your Friend”
Jody Chudley - Daily Reckoning - Thu Mar 26, 4:24PM CDT
This post “Imported Oil is Not Your Enemy. It Is Your Friend” appeared first on Daily Reckoning . To allow exports of oil or to not allow exports of oil? That has become a very important question. Today Jody Chudley takes a look at...
VLO: 63.62 (-0.14), PSX: 78.60 (-0.96), MPC: 102.39 (-0.51)

Is The Brent-WTI Spread About To Widen?
Lior Cohen - at Seeking Alpha - Thu Mar 26, 2:42PM CDT

VLO: 63.62 (-0.14), MPC: 102.39 (-0.51)

Valero Energy: A Value Play With Attractive Growth Catalysts
UGA Student Managed Investment Fund - at Seeking Alpha - Thu Mar 26, 2:11PM CDT

VLO: 63.62 (-0.14)

The March Madness 'Sweet 16' of Stocks - Analyst Blog
Sweta Killa - Zacks Investment Research - Thu Mar 26, 1:55PM CDT
From four top industry brackets, we can help fill out winners for your portfolio.
PBR.A: 6.09 (+0.09), A: 41.55 (-0.17), NEM: 21.71 (-0.31), ILMN: 185.64 (-1.98), MEI: 47.04 (+0.09), ANTM: 154.41 (-2.44), VLO: 63.62 (-0.14), WGP: 60.00 (-2.15), Q: 66.97 (-1.03), DGX: 76.85 (-0.84), JKHY: 69.89 (+0.22), CELP: 13.20 (-0.51), MOS: 46.06 (-1.30), MITK: 3.16 (-0.03)

Solving the Crude Storage Glut -- First, Get the Right Price
at The Street - Thu Mar 26, 12:05PM CDT
Dan Dicker, energy contributor at TheStreet.com talks to Jill Malandrino of Options Action about the singular focus of oil price based on quickly filling crude storage.
SU: 29.25 (+0.05), VLO: 63.62 (-0.14), TSO: 91.29 (+0.14), MPC: 102.39 (-0.51), CVX: 104.98 (-1.92)

Cowen raises estimates on six top refining stocks
Seeking Alpha - at Seeking Alpha - Thu Mar 26, 9:59AM CDT

VLO: 63.62 (-0.14), TSO: 91.29 (+0.14), MPC: 102.39 (-0.51), PBF: 33.92 (-0.29), WNR: 49.39 (-0.36), DK: 39.75 (-0.16)

Analyst: Three reasons U.S. refiners need not worry about narrower spreads
Seeking Alpha - at Seeking Alpha - Wed Mar 25, 4:45PM CDT

VLO: 63.62 (-0.14), MPC: 102.39 (-0.51), TSO: 91.29 (+0.14), PBF: 33.92 (-0.29), WNR: 49.39 (-0.36), DK: 39.75 (-0.16)

Selloff in Biotech Continues; Should You Worry About Tech Sector?
at The Street - Wed Mar 25, 1:28PM CDT
The CNBC ‘Fast Money Halftime’ trading panel looks at biotech stocks, the broader market and the tech sector.
BIIB: 422.24 (-9.38), TROW: 80.98 (-0.76), BLK: 365.84 (-2.26), XBI: 225.50 (+1.13), AMGN: 159.85 (-4.45), FNF: 36.76 (+0.17), IBB: 343.43 (-7.89), TLT: 130.69 (+0.28), TBT: 41.87 (-0.20), CELG: 115.28 (-4.74), VLO: 63.62 (-0.14), SPY: 206.43 (-1.82), QQQ: 105.60 (-1.13), GILD: 98.13 (-2.56), DIA: 177.58 (-1.81), XLK: 41.44 (-0.43), IWM: 124.37 (-0.40), XLF: 24.11 (-0.17), AAPL: 124.43 (-1.94), REGN: 451.48 (-8.30)

Once the Next "Big Thing" in Energy, Are Ethanol's Days Now Numbered?
Jason Hall and Travis Hoium, The Motley Fool - Motley Fool - Wed Mar 25, 12:03PM CDT
The world's energy needs are going to require a lot of sources to power the future. Ethanol has been widely used as a fuel additive in the United States, and currently makes up 10% (or in some cases more) of almost all of the gasoline sold...
VLO: 63.62 (-0.14), ADM: 47.40 (-0.02)

Regulatory Costs For Some Refiners Increased In FY 2014
Tristan R. Brown - at Seeking Alpha - Wed Mar 25, 9:13AM CDT

VLO: 63.62 (-0.14), LYB: 87.80 (+0.03), MPC: 102.39 (-0.51), PBF: 33.92 (-0.29), DAL: 44.96 (-0.60), WNR: 49.39 (-0.36), HFC: 40.27 (-0.50), ALJ: 16.57 (+0.59), CVRR: 20.74 (-0.01), CLMT: 24.05 (-0.79)

Strong On High Relative Volume: Valero Energy (VLO)
at The Street - Wed Mar 25, 9:08AM CDT
Trade-Ideas LLC identified Valero Energy (VLO) as a strong on high relative volume candidate
VLO: 63.62 (-0.14)

InsiderInsights.com Daily Round Up 3/23/15: ANF, OPK, HEES, MLNK
InsiderInsights - at Seeking Alpha - Tue Mar 24, 3:11PM CDT

MDGN: 8.06 (-0.16), FMBH: 20.00 (-1.10), DEI: 29.81 (-0.51), GARS: 14.90 (-0.07), MLNK: 3.85 (-0.03), GOOG: 548.00 (-4.03), VLO: 63.62 (-0.14), PN: 12.70 (-0.37), ESPR: 92.60 (+0.56), OPK: 14.17 (-0.54), ANF: 22.04 (+0.10), RSPP: 25.19 (-0.82), PTCT: 60.85 (-4.00), DYN: 31.43 (+0.55), ANAC: 57.85 (+1.04), GOOGL: 554.70 (-6.44), HEES: 24.99 (+0.45), EME: 46.47 (-0.43), SAEX: 3.42 (-0.16), ALCO: 51.26 (-1.46)

Scroll down for more posts ▼

Top 10 Most Recent News Articles

NARUTO Card Game Set for June 2027 Global Launch

Updated Category News Views 14

Mark Your Calendars: Global Launch June 2027 They're rolling out a red carpet for nostalgia here, I tell ya! At the New York Comic Con, BANDAI announced a worldwide launch for the NARUTO CARD GAME in June 2027. We'll see pre-built decks starring your favorite shinobi and a mad sprint to collect with the new booster packs. Feels sort of like they’re summoning a jutsu...

Continue Reading
Duolingo Faces Lawsuit Over Alleged Investor Missteps

Updated Category News Views 13

Fasten your seatbelts, folks. We're diving into a legal tussle that could shake things up for Duolingo, Inc. (NASDAQ: DUOL). Investors who plunged into Duolingo shares between May 2, 2025, and February 26, 2026, might be feeling the heat now. They ought to brace for a class-action lawsuit frenzy with fingers pointed at Duolingo for allegedly pulling wool over investors'...

Continue Reading
AI Drives Major Time Savings in Endoscopy Tech

Updated Category News Views 14

AI in Endoscopy: Game-Changer or Gimmick? Stumbling across AnX Robotica's latest pitch about their NaviCam ProScan AI workflow, one can't help but feel a mix of curiosity and skepticism. With the stakes in medical tech sky-high, they've fired off some impressive stats that grab attention. We're talking about cutting small-bowel capsule review times by a whopping...

Continue Reading
Sebela Pharma's Tegoprazan Posts Strong Phase 3 Data

Updated Category News Views 9

Spotlight on Tegoprazan: A New Player on the GERD Field Sometimes, a pharma company turns heads with data that speaks for itself. This time, Sebela Pharmaceuticals is doing just that with Tegoprazan's phase 3 results, shining a light on an area overlooked for too long: non-erosive reflux disease (NERD). Showing promise in its latest trials, Tegoprazan is muscling into the...

Continue Reading
LEGO Mashes Star Wars and Marvel for Fans' Delight

Updated Category News Views 14

A New Chapter in LEGO's Story Well, well, what do we have here? LEGO's throwing down the gauntlet. For the first time, they're asking fans to merge two colossal universes: Star Wars and Marvel. Talk about a brains-and-bricks bonanza! Announced at New York Comic Con with some star power from Kevin Smith, this LEGO Ideas challenge opens doors for fan creativity that might...

Continue Reading
Pacira BioSciences Faces Shareholder Revolt in M&A Deal

Updated Category News Views 4

A New Storm Brews Over Pacira's Sale to Viatris They say where there's smoke, there's fire, and it looks like Pacira BioSciences, Inc. (NASDAQ: PCRX) is running right into a bonfire thanks to their upcoming sale to Viatris Inc. On the face of it, shareholders are looking at a tidy $36.50 in cash per share, but not everyone's buying the deal as fair. Enter lawman Juan...

Continue Reading
Phase I of 2026 Hong Kong Trade Shows Highlights Innovation

Updated Category News Views 15

Hong Kong Takes Center Stage in Global Commerce Flip through the economic landscape today, and you’ll spot Hong Kong, decked out in its best as a trade linchpin—with over 2,100 suppliers gathered under one roof. AsiaWorld-Expo is buzzing with the commencement of Phase I of the October 2026 Global Sources Hong Kong Shows. The theme's all about 'Connecting Global...

Continue Reading
AbbVie's SKYRIZI and RINVOQ Highlight IBD Control Advances

Updated Category News Views 14

A Deeper Look Into AbbVie's Latest Data Let's cut straight to the science, folks. At the recent American College of Gastroenterology 2026 Annual Scientific Meeting, AbbVie pulled the curtain on 22 fresh scientific abstracts that are really shaking things up in the field of inflammatory bowel disease (IBD) treatment. Data from the Phase 3 AFFIRM study shined especially...

Continue Reading
Celltrion Unveils New Data on Infliximab: ACG 2026 Insight

Updated Category News Views 11

First Impressions: Celltrion's Latest Revelation Alright, let's jump straight into it. Celltrion USA is flaunting its latest findings on ZYMFENTRA® (infliximab-dyyb) for Crohn's disease and ulcerative colitis right at the American College of Gastroenterology's (ACG) grand event in 2026. If you've been watching the healthcare sector, this is significant news. It's got all...

Continue Reading
2026 Community Impact Week: Slam Dunk for Community Unity

Updated Category News Views 8

Alright, if you're looking for a story that gives you those warm fuzzy feelings while wrapping you in a big sports hug, here it is. Imagine this: you've got basketball legends, world-class athletes, and a corporate heavyweight, all huddling up to make a community impact that's more than just warm air. Hoops, Hope, and High Fives The NBA Cares x Sands Cares Community...

Continue Reading

Top 5 Most Recently Viewed Articles

Exploring Telehealth Trends: A Comprehensive Yearly Insight

Updated Category News Views 346

FAIR Health's Telehealth Tracker: A Milestone Year FAIR Health has reached a significant milestone with its Monthly Telehealth Regional Tracker entering its sixth year. This tracker provides valuable insights into how telehealth usage has evolved, empowering stakeholders to understand trends in healthcare delivery. New Features and Data Insights The latest iteration of...

Continue Reading
Exploring Analog Devices: A $1000 Investment Journey

Updated Category News Views 139

The Growth of Analog Devices Inc (NASDAQ: ADI) Investors have increasingly turned their attention to Analog Devices Inc, a leader in the semiconductor industry. Over the last five years, Analog Devices has consistently outperformed the market, showcasing an annualized return of 16.0%. With a current market capitalization standing at an impressive $119.42 billion, the...

Continue Reading
Celebrating Excellence in Clinical Simulation: Meet the Nominees

Updated Category News Views 110

Highlighting Excellence in Clinical Simulation Awards A Representation of the Best in Simulation Healthcare Education in 2024 Education Management Solutions (EMS), a frontrunner in healthcare simulation and competency management platforms, has proudly announced its nominees for the 16th Annual Excellence in Clinical Simulation Awards. Each year, this noteworthy event...

Continue Reading
Significant Oil Price Drop Benefits Airlines and Cruise Lines

Updated Category News Views 195

Oil Prices Experience a Significant Drop Amid Easing Tensions Oil prices witnessed a noticeable decrease recently, plummeting over 5% during early trading in New York. This shift came as geopolitical tensions in the Middle East appeared to stabilize after an assurance from Israeli Prime Minister Benjamin Netanyahu that Iran’s oil facilities would not be targets in any...

Continue Reading
RxSight, Inc. Faces Legal Challenges: Investors Invited to Join Lawsuit

Updated Category News Views 136

RxSight, Inc. Investors Invited to Participate in Class Action Lawsuit Investors of RxSight, Inc. are becoming aware of significant opportunities to engage in a class action lawsuit. This legal action is being initiated by Bronstein, Gewirtz & Grossman, LLC, a law firm with a national reputation for advocating on behalf of investors. They are notifying shareholders that...

Continue Reading